US Patent Issued to COCRYSTAL PHARMA on July 15 for "Pyrrolo[2,3-Bpyridin derivatives as inhibitors of influenza virus replication" (Washington Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,631, issued on July 15, was assigned to COCRYSTAL PHARMA INC. (Bothell, Wash.).

"Pyrrolo[2,3-Bpyridin derivatives as inhibitors of influenza virus replication" was invented by Irina C. Jacobson (Sammamish, Wash.), Sam SK Lee (Edmonds, Wash.) and Michael David Feese (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula A, B or C that can inhibit the replication of influenza viruses, reduce the amount of influenza viruses, and/or treat influenza."

The patent was filed on July 26, 2019, under Application No. 17/259,397.

*For further information, including images, charts and tables, please visit: http://patft...